메뉴 건너뛰기




Volumn 4, Issue 4, 2013, Pages 631-652

Metabolism-guided drug design

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE A2A RECEPTOR ANTAGONIST; ANAPLASTIC LYMPHOMA KINASE INHIBITOR; ANTIMALARIAL AGENT; ANTINEOPLASTIC AGENT; AROMATIC AMIDE; AZETIDINYL KETOLIDE DERIVATIVE; BLOOD CLOTTING FACTOR 10A INHIBITOR; CLOPIDOGREL; CYTOCHROME P450; DILTIAZEM DERIVATIVE; DNA; GAMMA SECRETASE INHIBITOR; GPR 119 RECEPTOR AGONIST; INDINAVIR; MELOXICAM; MINOXIDIL; NEW DRUG; PAROXETINE; PIOGLITAZONE; PIRAGLIATIN; PROTEIN; ROSIGLITAZONE; SEROTONIN 2C AGONIST; SODIUM GLUCOSE COTRANSPORTER 2 INHIBITOR; SUDOXICAM; THROMBIN INHIBITOR; TRIPTAN DERIVATIVE; TROGLITAZONE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VENLAFAXINE DERIVATIVE;

EID: 84876698035     PISSN: 20402503     EISSN: 20402511     Source Type: Journal    
DOI: 10.1039/c2md20317k     Document Type: Review
Times cited : (92)

References (113)
  • 38
    • 84876710237 scopus 로고    scopus 로고
    • Auspex Pharmaceuticals
    • Auspex Pharmaceuticals, http://www.auspexpharma.com/auspex-SD254.html
  • 86
    • 84890565608 scopus 로고    scopus 로고
    • A. T. Yarnell, http://pubs.acs.org/cen/science/87/8725scil.html
    • Yarnell, A.T.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.